About Baxalta
Baxalta is a company based in Chicago (United States) founded in 2015 was acquired by Shire in January 2016.. Baxalta offers products and services including Oncology Medicines, Rare Disease Therapies, and Vaccine Products. Baxalta operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Takeda Pharmaceutical Company Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Shire
(Jan 11, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Baxalta
Baxalta offers a comprehensive portfolio of products and services, including Oncology Medicines, Rare Disease Therapies, and Vaccine Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for cancer through innovative drug development
Solutions for immunology and metabolic disorders via clinical research
Infectious disease prevention through advanced manufacturing
Unlock access to complete
Unlock access to complete
Software Development Team
15 people
Leadership Team
7 people
Sales and Marketing
4 people
Legal and Compliance
3 people
Product Management Team
2 people
Global Team
2 people
Senior Team
2 people
Human Resources and Administration
1 people
Unlock access to complete
Funding Insights of Baxalta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Baxalta
Baxalta has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Rare disease treatments are developed by a specialty biopharmaceutical firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Baxalta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Baxalta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Baxalta Comparisons
Competitors of Baxalta
Baxalta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Baxalta
Frequently Asked Questions about Baxalta
When was Baxalta founded?
Baxalta was founded in 2015.
Where is Baxalta located?
Baxalta is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of Baxalta?
Flemming Ornskov is the current CEO of Baxalta.
What does Baxalta do?
Baxalta was founded in 2015 and is headquartered in Chicago, United States. Therapies targeting orphan diseases and underserved conditions are developed, manufactured, and commercialized within the biotechnology sector. Operations center on hematology, oncology, and immunology, with a product pipeline featuring biologics that incorporate novel mechanisms and advanced technology platforms.
Who are the top competitors of Baxalta?
Baxalta's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Baxalta offer?
Baxalta offers Oncology Medicines, Rare Disease Therapies, and Vaccine Products.
Who are Baxalta's investors?
Baxalta has 1 investor. Key investors include Takeda Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.